• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR SUPERA PERIPHERAL STENT SYSTEM; SELF EXPANDING PERIPHERAL STENT SYSTEM Back to Search Results
Model Number S-50-080-120-P6
Medical Device Problem Codes Difficult or Delayed Positioning (1157); Activation Failure (3270)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 02/18/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
The device was not returned for investigation.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot revealed no other incidents reported for this lot.The investigation was unable to determine a conclusive cause for the reported poor visibility, or the deployment difficulties (partial stent deployment, stent removed, deployed).It may be possible that anatomical conditions contributed to the deployment difficulty.It may be probable that the distal shaft was bent or entrapped in the anatomy such that the ratchet was unable to engage the stent properly to fully release the stent; however, this could not be confirmed.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
 
Event or Problem Description
It was reported that the procedure was to treat a restenosed, previously stented lesion located in the proximal popliteal and a distal occlusion.Due to patient anatomy, visualization was difficult.After it was thought that the stent was fully deployed, the stent delivery system (sds) was removed; however, the stent was only partially deployed and during removal of the sds, the stent was removed.There was no adverse patient effect or a clinically significant delay in procedure.Another supera was deployed successfully to complete the procedure.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SUPERA PERIPHERAL STENT SYSTEM
Common Device Name
SELF EXPANDING PERIPHERAL STENT SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9821692
Report Number2024168-2020-02301
Device Sequence Number19186830
Product Code NIP
UDI-Device Identifier08717648211751
UDI-Public08717648211751
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P120020
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/11/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date10/31/2021
Device Model NumberS-50-080-120-P6
Device Catalogue NumberS-50-080-120-P6
Device Lot Number9111261
Was Device Available for Evaluation? No
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/18/2020
Initial Report FDA Received Date03/11/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient Age57 YR
Patient Weight54
-
-